SOPHARMA AD (the “Company”) hereby informs that from 11 September 2014 up to and including 17 September 2014 the Company bought 2 500 own shares representing 0.0019% of the share capital of the Company, to the total value of 10 222.5 BGN on the Bulgarian Stock Exchange, the average price per share was 4.09 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 078 355, representing 3.85% of the share capital of the Company.

SOPHARMA AD hereby informs that from 18 September 2014 up to and including 24 September 2014 the Company bought 7 343 own shares representing 0.0056% of the share capital of the Company, to the total value of 29 212.2 BGN on the Bulgarian Stock Exchange, the average price per share was 3.98 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 085 698, representing 3.85% of the share capital of the Company.

Sopharma AD (the “Company”) notifies that for September 2014 the Company recorded an increase of sales revenues of 3% compared to the same month of 2013, including 6% increase of domestic sales and 2% increase of export sales. During the past nine months Sopharma AD recorded a decrease of sales revenues of 5%, including 3% increase of domestic sales and 8% decrease of export sales compared to the same period of 2013.

SOPHARMA AD hereby informs that from 2 October 2014 up to and including 8 October 2014 the Company bought 14 015 own shares representing 0.011% of the share capital of the Company, to the total value of 56 025.88 BGN on the Bulgarian Stock Exchange, the average price per share was 3.998 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 101 113, representing 3.86% of the share capital of the Company.

SOPHARMA AD hereby informs that from 9 October 2014 up to and including 15 October 2014 the Company bought 1 745 own shares representing 0.0013% of the share capital of the Company, to the total value of 6 955.83 BGN on the Bulgarian Stock Exchange, the average price per share was 3.99 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 102 858, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 16 October 2014 up to and including 22 October 2014 the Company bought 1 819 own shares representing 0.0014% of the share capital of the Company, to the total value of 7 188.11 BGN on the Bulgarian Stock Exchange, the average price per share was 3.95 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 104 677, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 23 October 2014 up to and including 29 October 2014 the Company bought 1 375 own shares representing 0.001% of the share capital of the Company, to the total value of 5389.9 BGN on the Bulgarian Stock Exchange, the average price per share was 3.92 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 106 052, representing 3.87% of the share capital of the Company.

Sopharma AD announces that the Company bought 770 ordinary registered shares with voting rights, representing 0.0455 of the share of the capital of Momina krepost AD. After this transaction the share of Sopharma AD in the capital of Momina krepost AD increased above 50% to 50.01%.

Sopharma will undertake the actions envisaged by the Law for public offering of securities art. 149 in relation to the fact that it now has exceeded the threshold of 50% in the capital of Momina krepost AD.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 21 March 2013 up to and including 27 March 2013 the Company bought 13480 own shares representing 0.010% of the share capital of the Company, to the total value of BGN 31354.20 on the Bulgarian Stock Exchange. The average price per share was BGN 2.32.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3666347, representing 2.777% of the share capital of the Company.

We would like to notify, that Sopharma AD received  the following opinion from Momina krepost AD:

On 27 March 2013, we received a notification pursuant to art. 151, par. 3 of POSA, accompanied by a tender offer under art. 149, par. 6 of POSA from Sopharma AD for purchasing of the shares of the remaining shareholders of Momina Krepost AD.

In accordance with art. 151, par. 5 of POSA and within the statutory period we present a motivated opinion regarding the tender offer.

І. Conditions of the tender offer